Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 43 citing articles:

An Updated Review of Computer‐Aided Drug Design and Its Application to COVID‐19
Arun Bahadur Gurung, M. Ajmal Ali, Joongku Lee, et al.
BioMed Research International (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 166
Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism
Riadh Badraoui, Mohd Adnan, Fevzi Bardakcı, et al.
Molecules (2021) Vol. 26, Iss. 3, pp. 673-673
Open Access | Times Cited: 45
In silico discovery of multi-targeting inhibitors for the COVID-19 treatment by molecular docking, molecular dynamics simulation studies, and ADMET predictions
Aso Hameed Hasan, Narmin Hamaamin Hussen, Sonam Shakya, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1645-1665
Closed Access | Times Cited: 29
Synthesis and greener pastures biological study of bis-thiadiazoles as potential Covid-19 drug candidates
Musa A. Said, Sayed M. Riyadh, Nadia S. Al‐Kaff, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 9, pp. 104101-104101
Open Access | Times Cited: 29
In silico Studies on the Interaction between Mpro and PLpro From SARS‐CoV‐2 and Ebselen, its Metabolites and Derivatives
Pablo A. Nogara, Folorunsho Bright Omage, Gustavo Roni Bolzan, et al.
Molecular Informatics (2021) Vol. 40, Iss. 8
Open Access | Times Cited: 40
DFT and MD simulation investigation of favipiravir as an emerging antiviral option against viral protease (3CLpro) of SARS-CoV-2
Pooja Yadav, Meenakshi Rana, Papia Chowdhury
Journal of Molecular Structure (2021) Vol. 1246, pp. 131253-131253
Open Access | Times Cited: 39
Folic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein
Yumeng Chen, Jinlai Wei, Rui-si Qin, et al.
Pharmaceutical Biology (2022) Vol. 60, Iss. 1, pp. 862-878
Open Access | Times Cited: 26
Carbon fullerene and nanotube are probable binders to multiple targets of SARS-CoV-2: Insights from computational modeling and molecular dynamic simulation studies
Sinosh Skariyachan, Dharshini Gopal, Dhrithi Deshpande, et al.
Infection Genetics and Evolution (2021) Vol. 96, pp. 105155-105155
Open Access | Times Cited: 30
In silico analysis of Phyllanthus amarus phytochemicals as potent drugs against SARS-CoV-2 main protease
T. P. Krishna Murthy, Trupthi Joshi, Shivani Gunnan, et al.
Current Research in Green and Sustainable Chemistry (2021) Vol. 4, pp. 100159-100159
Open Access | Times Cited: 24
Exploring Therapeutic Potentials of Natural Agents Against Breast Cancer Using Molecular Modeling
Nil Sazlı, Deniz Karataş
Genel Tıp Dergisi (2025) Vol. 35, Iss. 1, pp. 52-69
Open Access
A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)
Paolo Coghi, Li Yang, Jerome P. L. Ng, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 954-954
Open Access | Times Cited: 23
Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models
Yining Wang, Pengfei Li, Sajjan Rajpoot, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 21
In silico molecular docking of SARS-CoV-2 surface proteins with microbial non-ribosomal peptides: identification of potential drugs
Poonam Bansal, Raman Kumar, Jasbir Singh, et al.
Journal of Proteins and Proteomics (2021) Vol. 12, Iss. 3, pp. 177-184
Open Access | Times Cited: 20
Repurposing of approved drug molecules for viral infectious diseases: a molecular modelling approach
Nandan Kumar, Himakshi Sarma, G. Narahari Sastry
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 17, pp. 8056-8072
Closed Access | Times Cited: 15
Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
Vidya Niranjan, Anagha S Setlur, Chandrashekar Karunakaran, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1585-1608
Open Access | Times Cited: 11
Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach
Youness El Bakri, El Hassane Anouar, Sajjad Ahmad, et al.
Applied Biochemistry and Biotechnology (2021) Vol. 193, Iss. 11, pp. 3602-3623
Open Access | Times Cited: 14
Structure based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design
S. Anusuya, V. Anbazhagan, M. Michael Gromiha
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 29, pp. 2396-2409
Closed Access | Times Cited: 8
Identification of Novel Drug Molecules Against NS3-Like Helicase Enzyme of Alongshan Virus
Fizza Gul, Sajjad Ahmad, Kalsoom Khan, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 1
Synthesis, in vitro α-glucosidase inhibitory potential and in silico study of 2‑chloro pyridine incorporated thiosemicarbazones
Anam Rubbab Pasha, Saeed Ullah, Ajmal Khan, et al.
Journal of Molecular Structure (2024) Vol. 1317, pp. 139089-139089
Closed Access | Times Cited: 1
Targeting Omicron (B.1.1.529) SARS CoV-2 spike protein with selected phytochemicals: an in-silico approach for identification of potential drug
Hardeep Singh Tuli, Poonam Bansal, Varruchi Sharma, et al.
Journal of Experimental Biology and Agricultural Sciences (2022) Vol. 10, Iss. 2, pp. 396-404
Open Access | Times Cited: 6
Brief Communication: Caffeic Acid Derivatives and Polymethoxylated Flavonoids from Cat’s Whiskers (Orthosiphon stamineus) Form Stable Complexes with SARS-CoV Molecular Targets: An In silico Analysis
Siti Nur Athirah Mohd Kaspi, Nisha Govender, Zeti‐Azura Mohamed‐Hussein
Pertanika journal of tropical agricultural science (2022) Vol. 45, Iss. 1, pp. 235-244
Open Access | Times Cited: 5
Potential matrix metalloproteinase-9 inhibitor of aurone compound isolated from Sterculia quadrifida leaves: In-vitro and in-silico studies
Rollando Rollando, Warsito Warsito, Masruri Masruri, et al.
Research Journal of Pharmacy and Technology (2022), pp. 5250-5254
Closed Access | Times Cited: 5
A computational study on hydroxychloroquine binding to target proteins related to SARS-COV-2 infection
V.B. Navya, M.V. Hosur
Informatics in Medicine Unlocked (2021) Vol. 26, pp. 100714-100714
Open Access | Times Cited: 6
Arjunetin as a promising drug candidate against SARS-CoV-2: molecular dynamics simulation studies
Gandarvakottai Senthilkumar Arumugam, Asmita Sen, Swati Sucharita Dash, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 22, pp. 12358-12379
Open Access | Times Cited: 6
Identification of novel regulatory pathways across normal human bronchial epithelial cell lines (NHBEs) and peripheral blood mononuclear cell lines (PBMCs) in COVID-19 patients using transcriptome analysis
C Lavanya, Aajnaa Upadhyaya, Arpita Guha Neogi, et al.
Informatics in Medicine Unlocked (2022) Vol. 31, pp. 100979-100979
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top